Evidence map›Paper›PMID 38410866›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2024

A simple and effective genotyping workflow for rapid detection of CRISPR genome editing.

Lingxiang Wang, Jiale Wang, Dongfeng Feng, Bin Wang, Yasmin Jahan-Mihan, Ying Wang, Yan Bi, DoYoung Lim, Baoan Ji

Abstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Lingxiang WangDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States.
Jiale WangDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States.ORCID 0000-0001-8074-4138
Dongfeng FengDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States.
Bin WangDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States.
Yasmin Jahan-MihanDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States.
Ying WangDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States.
Yan BiDepartment of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States.ORCID 0000-0001-7427-6219
DoYoung LimThe Transgenic and Knockout Core, Mayo Clinic, Rochester, Minnesota, United States.
Baoan JiDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States.ORCID 0000-0001-8971-1463
Mayo Clinic in Florida · USMayo Clinic · USCentral South University · CNJacksonville College · US

Funding

Mechanisms of Hereditary PancreatitisR01DK117910 · NIDDK · MAYO CLINIC JACKSONVILLE · PI Baoan Ji, Ying Wang · 2019 to 2026
$3.5M
PRSS1 Mutation and Pancreatic Cancer TumorigenesisR01CA255068 · NCI · MAYO CLINIC JACKSONVILLE · PI JI, BAOAN · 2021 to 2025
$2.2M
HHS | NIH | National Cancer Institute (NCI) CA255068HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) DK117910NCI NIH HHS R01 CA255068NIDDK NIH HHS R01 DK117910
6 · The paper itself

Abstract

Genetically engineered mouse models play a pivotal role in the modeling of diseases, exploration of gene functions, and the development of novel therapies. In recent years, clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9)-mediated genome editing technology has revolutionized the process of developing such models by enabling precise genome modifications of the multiple interested genes simultaneously. Following genome editing, an efficient genotyping methodology is crucial for subsequent characterization. However, current genotyping methods are laborious, time-consuming, and costly. Here, using targeting the mouse trypsinogen genes as an example, we introduced common applications of CRISPR-Cas9 editing and a streamlined cost-effective genotyping workflow for CRISPR-edited mouse models, in which Sanger sequencing is required only at the initial steps. In the F0 mice, we focused on identifying the presence of positive editing by PCR followed by Sanger sequencing without the need to know the exact sequences, simplifying the initial screening. In the F1 mice, Sanger sequencing and algorithms decoding were used to identify the precise editing. Once the edited sequence was established, a simple and effective genotyping strategy was established to distinguish homozygous and heterozygous status by PCR from tail DNA. The genotyping workflow applies to deletions as small as one nucleotide, multiple-gene knockout, and knockin studies. This simplified, efficient, and cost-effective genotyping shall be instructive to new investigators who are unfamiliar with characterizing CRISPR-Cas9-edited mouse strains.

Indexed as

CRISPR-Cas SystemsGene EditingAnimalsCRISPR-Associated Protein 9GenotypeMiceTrypsinogenWorkflowCRISPR-Associated Protein 9TrypsinogenCRISPRgenetic targetinggenotypingPCRtrypsinogen

Identifiers

PMID38410866
PMCPMC11216750
OpenAlexW4392197439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.